Table 1.
EXT | SLF | |||
---|---|---|---|---|
|
||||
First Trial | Trials 2–5 | First Trial | Trials 2–5 | |
SCM | 62.49 ± 4.75 | 73.33 ± 6.28 | 69.35 ± 4.96 | 75.53 ± 6.04 |
DLT | 67.19 ± 4.39 | 76.54 ± 8.50 | 81.37 ± 11.49 | 102.82 ± 21.38 |
BIC | 72.42 ± 7.91 | 87.00 ± 9.90 | 80.76 ± 13.95 | 102.09 ± 24.58 |
GAS | 92.12 ± 9.85 | 95.83 ± 11.00 | 90.73 ± 7.49 | 86.13 ± 13.28 |
TA | 65.71 ± 4.43 | 68.84 ± 3.97 | 75.37 ± 6.88 | 78.26 ± 5.92 |
EXT = externally activated SLF = self-activated drop perturbations
SCM= sternocleidomastoid, DLT= deltoid, BIC=biceps brachii, GAS= medial gastrocnemius, TA=tibialis anterior